LTB4R2 and prostate carcinoma: Previously, BLT2 has been shown to be increased in ovarian, bladder, and prostate cancers, and elevated BLT2 levels have been associated with cancer cell survival, chemoresistance and metastasis [20, 21, 38, 39].